New lipidic peptide IK14004 shows promise in treating cancer and reducing autoimmune complications Post author: Post published:November 15, 2023 Post category:uncategorized A lipidic peptide, named IK14004. You Might Also Like evitria Partners with Sapio Sciences to Streamline Antibody Workflow Management and Reporting December 4, 2024 Engaging partners in the breastfeeding journey January 21, 2024 MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals February 9, 2024
evitria Partners with Sapio Sciences to Streamline Antibody Workflow Management and Reporting December 4, 2024